HDFC Pharma And Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹0.95% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
- Rating
Not Rated - Minimum Investment₹100
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹2612 Cr
- Created on3 Oct 2023
Fund Ranking
#
/ 15 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
- 6 Month27.1%
- 1 Year19.4%
- 3 Year (CAGR)-
- All Time (CAGR)30.4%
Category Return
- 6 Month21.5%
- 1 Year13.1%
- 3 Year (CAGR)22.0%
- All Time (CAGR)-
Asset Allocation
- Equity97.3%
- Other2.8%
Top 5 Holdings
Top 5 Sectors
- Cipla2.89%
- Ipca Laboratories4.56%
- Lupin6.04%
- Shilpa Medicare1.32%
- Sun Pharmaceutical Industries10.79%
Fund Information
- Expense Ratio2.20%
- Exit LoadNo Exit Load
- Lock-In PeriodNo Lock-In
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 0.00 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 0.00 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. 0.00 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 0.00